A Prospective, Observational Study of the PPI Non-responder

Clinical Trial ID NCT03282084

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03282084

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 8.51
2 Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013 6.82
3 Clinical guideline: management of gastroparesis. Am J Gastroenterol 2012 3.86
4 Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976 3.71
5 Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006 3.51
6 The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005 2.23
7 Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther 2010 1.45
8 Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil 2011 1.32
9 How to manage refractory GERD. Nat Clin Pract Gastroenterol Hepatol 2007 1.05
10 Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease. World J Gastroenterol 2013 1.01
11 Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD. Am J Gastroenterol 2011 0.98
12 Timely confirmation of gastro-esophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations. Curr Med Res Opin 2008 0.98
13 Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol 2013 0.84
Next 100